Evidence map›Paper›PMID 33381758›Full record

ArticleBrain communications2020

Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy.

Nga Yan Tse, Yu Chen, Muireann Irish, Nicholas J Cordato, Ramon Landin-Romero, John R Hodges, Olivier Piguet, Rebekah M Ahmed

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Observational
  6. Review
  7. Review
  8. Review
  9. Pathology-specific patterns of cerebellar atrophy in neurodegenerative disorders.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nga Yan TseCentral Sydney Medical School and Brain and Mind Centre, The University of Sydney, Sydney, Australia.ORCID 0000-0002-1471-4835
Yu ChenSchool of Psychology and Brain and Mind Centre, The University of Sydney, Sydney, Australia.ORCID 0000-0001-5863-7002
Muireann IrishSchool of Psychology and Brain and Mind Centre, The University of Sydney, Sydney, Australia.ORCID 0000-0002-4950-8169
Nicholas J CordatoFaculty of Medicine, The University of New South Wales, Sydney, Australia.ORCID 0000-0002-4436-0871
Ramon Landin-RomeroSchool of Psychology and Brain and Mind Centre, The University of Sydney, Sydney, Australia.ORCID 0000-0003-0485-8090
John R HodgesCentral Sydney Medical School and Brain and Mind Centre, The University of Sydney, Sydney, Australia.
Olivier PiguetSchool of Psychology and Brain and Mind Centre, The University of Sydney, Sydney, Australia.
Rebekah M AhmedCentral Sydney Medical School and Brain and Mind Centre, The University of Sydney, Sydney, Australia.
The University of Sydney · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mounting evidence suggests an association between cerebellar atrophy and cognitive impairment in the main frontotemporal dementia syndromes. In contrast, whether cerebellar atrophy is present in the motor syndromes associated with frontotemporal lobar degeneration (corticobasal syndrome and progressive supranuclear palsy) and the extent of its contribution to their cognitive profile remain poorly understood. The current study aimed to comprehensively chart profiles of cognitive impairment in relation to cerebellar atrophy in 49 dementia patients (corticobasal syndrome = 33; progressive supranuclear palsy = 16) compared to 33 age-, sex- and education-matched healthy controls. Relative to controls, corticobasal syndrome and progressive supranuclear palsy patients demonstrated characteristic cognitive impairment, spanning the majority of cognitive domains including attention and processing speed, language, working memory, and executive function with relative preservation of verbal and nonverbal memory. Voxel-based morphometry analysis revealed largely overlapping patterns of cerebellar atrophy in corticobasal syndrome and progressive supranuclear palsy relative to controls, primarily involving bilateral Crus II extending into adjacent lobules VIIb and VIIIa. After controlling for overall cerebral atrophy and disease duration, exploratory voxel-wise general linear model analysis revealed distinct cerebellar subregions differentially implicated across cognitive domains in each patient group. In corticobasal syndrome, reduction in grey matter intensity in the left Crus I was significantly correlated with executive dysfunction. In progressive supranuclear palsy, integrity of the vermis and adjacent right lobules I-IV was significantly associated with language performance. These results are consistent with the well-established role of Crus I in executive functions and provide further supporting evidence for vermal involvement in cognitive processing. The current study presents the first detailed exploration of the role of cerebellar atrophy in cognitive deficits in corticobasal syndrome and progressive supranuclear palsy, offering insights into the cerebellum's contribution to cognitive processing even in neurodegenerative syndromes characterized by motor impairment.

Indexed as

Cerebellar atrophycognitive impairmentcorticobasal syndromefrontotemporal dementiaprogressive supranuclear palsy

Identifiers

PMID33381758
PMCPMC7753056
OpenAlexW3099923866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.